1-(Cyclobutanecarbonyl)piperidine-3-carboxylic acid

Catalog No. :
ACTGXJ647
CAS No. :
926214-73-5
Molecular Formula :
C11H17NO3
Molecular Weight :
211.26

IUPAC Name:1-(cyclobutanecarbonyl)piperidine-3-carboxylic acid

1-(Cyclobutanecarbonyl)piperidine-3-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$82.00Login to see priceIn stockInquiry
1g95%$150.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(Cyclobutanecarbonyl)piperidine-3-carboxylic acid
IUPAC Name1-(cyclobutanecarbonyl)piperidine-3-carboxylic acid
MDL No.MFCD09043166
Molecular FormulaC11H17NO3
Molecular Weight211.26
SMILESO=C(C1CN(C(C2CCC2)=O)CCC1)O
InChI KeyXFWRSHGZIGKYAP-UHFFFAOYSA-N
Synonym1-(CYCLOBUTYLCARBONYL)-3-PIPERIDINECARBOXYLIC ACID;AKOS BBV-006904;UKRORGSYN-BB BBV-006904;1-(cyclobutylcarbonyl)-3-piperidinecarboxylic acid(SALTDATA: FREE);1-(cyclobutanecarbonyl)nipecotic acid;1-(cyclobutanecarbonyl)piperidine-3-carboxylic acid;1-(cyclobutyl-oxomethyl)-3-piperidinecarboxylic acid;3-Piperidinecarboxylic acid, 1-(cyclobutylcarbonyl)-
CAS No.926214-73-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACTGXJ647 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTGXJ647 route product structure diagram
    ACTGXJ647926214-73-5 In Stock
Inquiry

2. ACTGXJ647 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTGXJ647 route product structure diagram
    ACTGXJ647926214-73-5 In Stock
Inquiry

Comments (0)